🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, open-label, dose escalation study in patients with advan...
Status
Completed
Location
Next Oncology
Start Date
2020-09-23
Trial ID
NCT04501276
Treatments Being Tested
This is an open label, lead in phase Ib dose confirmation study in patients...
Status
Active Not Recruiting
Location
National University Hospital
Start Date
2022-05-19
Trial ID
NCT05275777
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, multicenter study of ADG106...
Status
Completed
Location
Horizon Oncology Research
Start Date
2018-09-17
Trial ID
NCT03707093
Treatments Being Tested
This is a Phase 1, open-label, dose-escalation, single-center study of ADG1...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2018-12-20
Trial ID
NCT03802955
Treatments Being Tested
This is a phase Ib followed by phase II clinical trial evaluating the safet...
Status
Recruiting
Location
National University Hospital
Start Date
2023-06-12
Trial ID
NCT05491083
Treatments Being Tested
This is an open label, non-randomised phase 1b/2 study including patients w...
Status
Unknown
Location
National Cancer Centre Singapore
Start Date
2021-11-12
Trial ID
NCT05236608
ADG126, ADG126 in Combination with anti-PD1 antibody, and ADG126 in Combina...
Status
Completed
Location
University of California Los Angeles
Start Date
2021-03-15
Trial ID
NCT04645069
Treatments Being Tested
This is a Multicenter, Open-Label, Phase Ib/II Study of ADG106 in Combinati...
Status
Terminated
Location
Sun Yat-Sen University Cancer Center
Start Date
2021-03-11
Trial ID
NCT04775680
Treatments Being Tested